The nation of Zimbabwe has rejected a substantial American health deal worth $367m (£272m) over five years because of the United States' request for confidential information.
The decision was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official representative later stated that the US was requesting health data for scientific study and profit but refused to guarantee the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more dialogue to secure a agreement suitable to all parties so the country's critical HIV programme can proceed.
Broader Implications
This rejection follows a similar situation in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were raised about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.
Based on reports, 16 nations in Africa have so far signed these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding guarantee of access to any medical innovations – like new medicines or tests – that might be developed from that provided information," his statement read.
"Put simply, our country would supply the raw materials for medical research with no certainty that the end products would be accessible to our population should a future disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks previously set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This framework is intended to guarantee that when a country provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage further discussions with our American counterparts on how future co-operation could be structured in a way that respects the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but suggested that talks need to persist considering a large portion of the country's Aids initiatives relied on international support.
"If specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it added.
This impasse emphasises the ongoing challenges between receiving crucial international aid and protecting local interests in an increasingly data-driven world.